Clinical Trial Update: Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study evaluating the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) for treating ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Damage

Drugs mentioned

• HUC-MSC (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: BIONCaRT GmbH | Conditions: Cartilage Damage | Phase 1, Phase 2 | Status: RECRUITING